AR083221A1 - Proceso para producir dialquilfosfotriesteres de nucleosidos mediante transesterificacion enzimatica y desproteccion de los mismos para producir nucleosidos monofosfato - Google Patents
Proceso para producir dialquilfosfotriesteres de nucleosidos mediante transesterificacion enzimatica y desproteccion de los mismos para producir nucleosidos monofosfatoInfo
- Publication number
- AR083221A1 AR083221A1 ARP110103609A ARP110103609A AR083221A1 AR 083221 A1 AR083221 A1 AR 083221A1 AR P110103609 A ARP110103609 A AR P110103609A AR P110103609 A ARP110103609 A AR P110103609A AR 083221 A1 AR083221 A1 AR 083221A1
- Authority
- AR
- Argentina
- Prior art keywords
- nucleoside
- phosphotriester
- produce
- dialkyl
- monophosphate
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 230000002255 enzymatic effect Effects 0.000 title abstract 2
- 238000005809 transesterification reaction Methods 0.000 title abstract 2
- VZQXUWKZDSEQRR-UHFFFAOYSA-N Nucleosid Natural products C12=NC(SC)=NC(NCC=C(C)C)=C2N=CN1C1OC(CO)C(O)C1O VZQXUWKZDSEQRR-UHFFFAOYSA-N 0.000 title 1
- 238000010511 deprotection reaction Methods 0.000 title 1
- 150000004712 monophosphates Chemical class 0.000 title 1
- 239000002777 nucleoside Substances 0.000 abstract 9
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 6
- 102000004203 Phosphoric Triester Hydrolases Human genes 0.000 abstract 3
- 108090000754 Phosphoric Triester Hydrolases Proteins 0.000 abstract 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract 3
- -1 monophosphate nucleoside Chemical class 0.000 abstract 3
- 229910019142 PO4 Inorganic materials 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 2
- 239000010452 phosphate Substances 0.000 abstract 2
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 239000013043 chemical agent Substances 0.000 abstract 1
- 238000005984 hydrogenation reaction Methods 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/04—Phosphoric diester hydrolases (3.1.4)
- C12Y301/04001—Phosphodiesterase I (3.1.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/08—Phosphoric triester hydrolases (3.1.8)
- C12Y301/08001—Aryldialkylphosphatase (3.1.8.1), i.e. paraoxonase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Reivindicación 1: Un proceso para producir un dialquilfosfotriéster de nucleósido, donde el proceso comprende la reacción de un nucleósido con un compuesto fosfotriéster activado como un dador de fosfato en presencia de una enzima fosfotriesterasa.Reivindicación 12: Un proceso para producir un nucleósido monofosfato monoéster, el proceso que comprende las etapas de: a) conducir la transesterificación enzimática de acuerdo con la reivindicación 1, mediante la reacción de un nucleósido con un compuesto fosfotriéster activado como un dador de fosfato en presencia de una enzima fosfotriesterasa, b) eliminar los grupos alquilo del dialquilfosfotriéster de nucleósido obtenido en la etapa (a) mediante reacción con un agente químico seleccionado del grupo de reactivos básicos inorgánicos u orgánicos, reactivos ácidos inorgánicos u orgánicos, tioalcoholes y reactivos de hidrogenación, o c) eliminar los grupos alquilo del dialquilfosfotriéster de nucleósido obtenido en la etapa (a) mediante hidrólisis de acuerdo con las siguientes etapas: i) incubar el dialquilfosfotriéster de nucleósido en presencia de una enzima fosfotriesterasa, ii) incubar el alquilfosfodiéster de nucleósido de la etapa (i) en presencia de una enzima fosfodiesterasa, y recoger el nucleósido monofosfato de la mezcla de reacción.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38767010P | 2010-09-29 | 2010-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR083221A1 true AR083221A1 (es) | 2013-02-06 |
Family
ID=44773066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110103609A AR083221A1 (es) | 2010-09-29 | 2011-09-29 | Proceso para producir dialquilfosfotriesteres de nucleosidos mediante transesterificacion enzimatica y desproteccion de los mismos para producir nucleosidos monofosfato |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR083221A1 (es) |
| WO (1) | WO2012041965A1 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201610936RA (en) | 2011-12-22 | 2017-02-27 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| HUE029038T2 (en) | 2012-05-25 | 2017-01-30 | Janssen Sciences Ireland Uc | Uracil spirooxetan nucleosides |
| GEP201706757B (en) | 2012-12-21 | 2017-10-25 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| BR112015025766A2 (pt) | 2013-04-12 | 2017-10-17 | Achillion Pharmaceuticals Inc | derivado de nucleosídeo altamente ativo para o tratamento de hcv |
| JP6562908B2 (ja) | 2013-10-11 | 2019-08-21 | ヤンセン バイオファーマ インク． | 置換ヌクレオシド、置換ヌクレオチドおよびその類似体 |
| GEP20217282B (en) | 2015-03-06 | 2021-08-10 | Atea Pharmaceuticals Inc | β-D-2'-DEOXY-2'α-FLUORO-2'-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT |
| WO2017024310A1 (en) | 2015-08-06 | 2017-02-09 | Chimerix, Inc. | Pyrrolopyrimidine nucleosides and analogs thereof useful as antiviral agents |
| PT3512863T (pt) | 2016-09-07 | 2022-03-09 | Atea Pharmaceuticals Inc | Nucleótidos de purina 2'-substituídos-n6-substituídos para tratamento de vírus de rna |
| CN110248951B (zh) | 2017-02-01 | 2022-10-28 | 阿堤亚制药公司 | 用于治疗丙型肝炎病毒的核苷酸半硫酸盐 |
| WO2019060692A1 (en) | 2017-09-21 | 2019-03-28 | Chimerix, Inc. | MORPHIC FORMS OF 4-AMINO-7- (3,4-DIHYDROXY-5- (HYDROXYMETHYL) -ETRAHYDROFURAN-2-YL) -2-METHYL-7H-PYRROLO [2,3-D] PYRIMIDINE-5-CARBOXAMIDE AND THEIR USES |
| WO2019200005A1 (en) | 2018-04-10 | 2019-10-17 | Atea Pharmaceuticals, Inc. | Treatment of hcv infected patients with cirrhosis |
| US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
| BR112023026356A2 (pt) | 2021-06-17 | 2024-03-05 | Atea Pharmaceuticals Inc | Método para tratar vírus da hepatite c ou uma condição resultante de uma infecção por hepatite c, combinação, uso da combinação, composição farmacêutica, e, kit para o tratamento de vírus da hepatite c |
| EP4493573A1 (en) | 2022-03-15 | 2025-01-22 | Rome Therapeutics, Inc. | Compounds and methods for treating disease |
| WO2024086592A2 (en) * | 2022-10-17 | 2024-04-25 | Emory Unversity | 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756315A (en) | 1989-12-05 | 1998-05-26 | Kyowa Hakko Kogyo Co., Ltd. | Inosine-guanosine kinase |
| US6987008B1 (en) | 1999-09-03 | 2006-01-17 | Ajinomoto Co., Inc. | Variant nucleoside-5′-phosphate producing enzyme |
| AUPR502301A0 (en) * | 2001-05-15 | 2001-06-07 | Commonwealth Scientific And Industrial Research Organisation | Phosphotriesterase from Agrobacterium radiobacter P230 |
-
2011
- 2011-09-29 WO PCT/EP2011/066988 patent/WO2012041965A1/en not_active Ceased
- 2011-09-29 AR ARP110103609A patent/AR083221A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012041965A1 (en) | 2012-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20120534A (es) | Sistesis estereoselectiva de activos que contienen fósforo | |
| CL2020002805A1 (es) | Método para identificar un modulador de un sistema biológico; método para identificar un modulador de un proceso de enfermedad (divisional 201302526) | |
| CO6551739A2 (es) | Mètodos para mejorar la eficacia de las reacciones de sacrificaciòn y fementaciòn simultaneas | |
| PE20121436A1 (es) | Metodo para la produccion enzimatica de acido 3-hidroxi-3-metilbutirico a partir de acetona y acetil-coa | |
| BR112013030492A2 (pt) | método para produzir um produto de tecido, produto de tecido produzido por um processo, método de tratamento, e sistema de tratamento | |
| UY33310A (es) | Sintesis estereoselectiva de activos que contienen fosforo | |
| BR112015006255A2 (pt) | Métodos para a produção de produtos químicos e derivados dos mesmos | |
| EA201490056A1 (ru) | Способы и композиции для получения растений, обладающих мужской стерильностью | |
| NZ728437A (en) | Methods for increasing cas9-mediated engineering efficiency | |
| EP2385955A4 (en) | MODIFIED ANTIBODY COMPOSITIONS, METHOD FOR THEIR PREPARATION AND USE | |
| EA202191796A2 (ru) | Способ сайт-специфического ферментативного мечения нуклеиновых кислот in vitro введением не встречающихся в природе нуклеотидов | |
| AR084774A1 (es) | Moleculas de acido nucleico que confieren resistencia a plagas coleopteros | |
| MX2016007029A (es) | Proceso para la produccion de azucares de biomasa. | |
| CL2013000427A1 (es) | Metodo para extraer litio de alta pureza de solucion portadora de litio por electrolisis que comprende preparar solucion acuosa de fosfato de litio a partir de solucion portadora de litio agregando material proveedor de fosforo, extraer litio de dicha solucion utilizando dispositivo electrolitico. | |
| TR201901838T4 (tr) | Mineral yün için düşük uçucu organik bileşikler salımlı haşıllama bileşimi ve elde edilen yalıtım ürünleri. | |
| ECSP099342A (es) | Purinas como inhibidores de la pkc theta | |
| BR112013030262A2 (pt) | processo de hidroformilação | |
| BR112017018063A2 (pt) | processo para preparação de um composto, uso de um composto, e, composição | |
| EA201270463A1 (ru) | Способ и реагенты для ингибирования или уменьшения образования отложений на стенках трубопроводов во время получения фосфорной кислоты | |
| BR112014002068A2 (pt) | método para preparação de grafeno funcionalizado | |
| MX2015004415A (es) | Compuestos de organofosforo para espumas de poliuretano retardantes de llama. | |
| BR112012015119A2 (pt) | "ácidos graxos de cadeia ramificada e produção biológica dos mesmos". | |
| MX2018011052A (es) | Compuestos y metodos para la sintesis de fosforamidato de 5-(n-triptamina carboxamida protegida)-2'-desoxiuridina para ser incorporados en una secuencia nucleica. | |
| BR112015030815A2 (pt) | polímeros fosforilados | |
| EP4249603A3 (en) | Design and development of novel detergents for use in pcr systems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |